25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. 2010

Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
One Veterans Dr. (111J), Minneapolis, MN 55417, USA. slini001@umn.edu

OBJECTIVE To test the hypothesis that lower 25-hydroxyvitamin D [25(OH)D] levels are associated with a greater likelihood of cognitive impairment and risk of cognitive decline. METHODS We measured 25(OH)D and assessed cognitive function using the Modified Mini-Mental State Examination (3MS) and Trail Making Test Part B (Trails B) in a cohort of 1,604 men enrolled in the Osteoporotic Fractures in Men Study and followed them for an average of 4.6 years for changes in cognitive function. RESULTS In a model adjusted for age, season, and site, men with lower 25(OH)D levels seemed to have a higher odds of cognitive impairment, but the test for trend did not reach significance (impairment by 3MS: odds ratio [OR] 1.84, 95% confidence interval [CI] 0.81-4.19 for quartile [Q] 1; 1.41, 0.61-3.28 for Q2; and 1.18, 0.50-2.81 for Q3, compared with Q4 [referent group; p trend = 0.12]; and impairment by Trails B: OR 1.66, 95% CI 0.98-2.82 for Q1; 0.96, 0.54-1.69 for Q2; and 1.30, 0.76-2.22 for Q3, compared with Q4 [p trend = 0.12]). Adjustment for age and education further attenuated the relationships. There was a trend for an independent association between lower 25(OH)D levels and odds of cognitive decline by 3MS performance (multivariable OR 1.41, 95% CI 0.89-2.23 for Q1; 1.28, 0.84-1.95 for Q2; and 1.06, 0.70-1.62 for Q3, compared with Q4 [p = 0.10]), but no association with cognitive decline by Trails B. CONCLUSIONS We found little evidence of independent associations between lower 25-hydroxyvitamin D level and baseline global and executive cognitive function or incident cognitive decline.

UI MeSH Term Description Entries
D008297 Male Males
D008609 Mental Status Schedule Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions.
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012111 Residence Characteristics Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services. Community,Domicile,Living Arrangements,Neighborhood,Place of Birth,Residential Selection,Arrangement, Living,Birth Place,Communities,Domiciles,Living Arrangement,Neighborhoods,Residence Characteristic
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
March 2016, JAMA neurology,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
March 2016, JAMA neurology,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
July 2009, Journal of neurology, neurosurgery, and psychiatry,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
March 2016, JAMA neurology,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
March 2014, The British journal of nutrition,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
February 1998, Metabolism: clinical and experimental,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
January 2015, Neuropsychiatric disease and treatment,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
June 2013, Clinical journal of the American Society of Nephrology : CJASN,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
March 2019, Journal of bone and mineral metabolism,
Y Slinin, and M L Paudel, and B C Taylor, and H A Fink, and A Ishani, and M T Canales, and K Yaffe, and E Barrett-Connor, and E S Orwoll, and J M Shikany, and E S Leblanc, and J A Cauley, and K E Ensrud, and
November 1977, Pediatrics,
Copied contents to your clipboard!